The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
Open accessAbstract
We have recently reported that therapeutic mesenchymal stromal cells (MSCs) have low engraftment and trigger the instant blood mediated inflammatory reaction (IBMIR) after systemic delivery to patients, resulting in compromised cell function. In order to optimize the product, we compared the immunomodulatory, blood regulatory, and therapeutic properties of freeze-thawed and freshly harvested cells. We found that freeze-thawed MSCs, as opposed to cells harvested from continuous cultures, have impaired immunomodulatory and blood regulatory properties. Freeze-thawed MSCs demonstrated reduced responsiveness to proinflammatory stimuli, an impaired production of anti-inflammatory mediators, increased triggering of the IBMIR, and a strong activation of the complement cascade compared to fresh cells. This resulted in twice the efficiency in lysis of thawed MSCs after 1 hour of serum exposure. We found a 50% and 80% reduction in viable cells with freshly detached as opposed to thawed in vitro cells, indicating a small benefit for fresh cells. In evaluation of clinical response, we report a trend that fresh cells, and cells of low passage, demonstrate improved clinical outcome. Patients treated with freshly harvested cells in low passage had a 100% response rate, twice the response rate of 50% observed in a comparable group of patients treated with freeze-thawed cells at higher passage. We conclude that cryobanked MSCs have reduced immunomodulatory and blood regulatory properties directly after thawing, resulting in faster complement-mediated elimination after blood exposure. These changes seem to be paired by differences in therapeutic efficacy in treatment of immune ailments after hematopoietic stem cell transplantation. Stem Cells 2014;32:2430–2442
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,410
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Self-citationLe Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal stem cells: immune evasive, not immune privileged
Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2816 · Cited by 1,531
Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., & Ringdén, O. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01176.x · Cited by 1,368
Bianco, P., Cao, X., Frenette, P. S., Mao, J. J., Robey, P. G., Simmons, P. J., & Wang, C.-Y. (2013) · Nature Medicine · doi:10.1038/nm.3028 · Cited by 1,197
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Mesenchymal Stem Cells: Mechanisms of Inflammation
Singer, N. G., & Caplan, A. I. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130230 · Cited by 851
Mesenchymal stem cell therapy: Two steps forward, one step back
Ankrum, J., & Karp, J. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.02.005 · Cited by 614
von Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., & Le Blanc, K. (2012) · Stem Cells · doi:10.1002/stem.1118 · Cited by 577
Self-citationTransplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
Le Blanc, K., Samuelsson, H., Gustafsson, B., Remberger, M., Sundberg, B., Arvidson, J., Ljungman, P., Lönnies, H., Nava, S., & Ringdén, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404777 · Cited by 443
Self-citationFrançois, M., Copland, I. B., Yuan, S., Romieu-Mourez, R., Waller, E. K., & Galipeau, J. (2012) · Cytotherapy · doi:10.3109/14653249.2011.623691 · Cited by 375
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Moll, G., Rasmusson-Duprez, I., von Bahr, L., Connolly-Andersen, A.-M., Elgue, G., Funke, L., Hamad, O. A., Lönnies, H., Magnusson, P. U., Sanchez, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1111 · Cited by 357
Self-citationvon Bahr, L., Sundberg, B., Lönnies, L., Sander, B., Karbach, H., Hägglund, H., Ljungman, P., Gustafsson, B., Karlsson, H., Le Blanc, K., et al. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2011.07.023 · Cited by 318
Self-citationTherapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements
Doorn, J., Moll, G., Le Blanc, K., van Blitterswijk, C., & de Boer, J. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0488 · Cited by 307
Self-citationProperdin: Emerging Roles of a Pattern-Recognition Molecule
Kemper, C., Atkinson, J. P., & Hourcade, D. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101250 · Cited by 228
Tatsumi, K., Ohashi, K., Matsubara, Y., Kohori, A., Ohno, T., Kakidachi, H., Horii, A., Kanegae, K., Utoh, R., Iwata, T., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.134 · Cited by 208
Mini‐review: A pivotal role for innate immunity in the clearance of apoptotic cells
Roos, A., Xu, W., Castellano, G., Nauta, A. J., Garred, P., Daha, M. R., & van Kooten, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200424904 · Cited by 168
Mesenchymal stem cells are injured by complement after their contact with serum
Li, Y., & Lin, F. (2012) · Blood · doi:10.1182/blood-2012-03-420612 · Cited by 167
Moll, G., Jitschin, R., von Bahr, L., Rasmusson, I., Sundberg, B., Lönnies, L., Elgue, G., Nilsson‐Ekdahl, K., Mougiakakos, D., Lambris, J. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021703 · Cited by 166
Self-citationQuimby, J. M., Webb, T. L., Habenicht, L. M., & DOW, S. W. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt198 · Cited by 150
Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?
Nilsson, B., Korsgren, O., Lambris, J. D., & Ekdahl, K. N. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.005 · Cited by 138
Self-citationGinis, I., Grinblat, B., & Shirvan, M. (2011) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2011.0395 · Cited by 116
Tissue-Engineered Airway: A Regenerative Solution
Jungebluth, P., Moll, G., Baiguera, S., & Macchiarini, P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.270 · Cited by 98
Self-citationRegulation of stem cell therapies under attack in Europe: for whom the bell tolls
Bianco, P., Barker, R. A., Brüstle, O., Cattaneo, E. F., Clevers, H. C., Daley, G. Q., Luca, M. D., Goldstein, L. S. B., Lindvall, O., Mummery, C. L., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.114 · Cited by 86
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Moll, G., Hult, A. K., von Bahr, L., Alm, J. J., Heldring, N., Hamad, O. A., Funke, L., Larsson, S., Teramura, Y., Roelofs, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085040 · Cited by 79
Self-citationAlagesan, S., & Griffin, M. D. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000043 · Cited by 78
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells
Samuelsson, H., Ringdén, O. T. H., Lönnies, H., & Blanc, K. L. (2009) · Cytotherapy · doi:10.1080/14653240802684194 · Cited by 75
Self-citationA Regulatory Role for Complement in Innate Immunity and Autoimmunity
Nauta, A. J., Roos, A., & Daha, M. R. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000079261 · Cited by 65
AN APPETITE FOR APOPTOTIC CELLS? CONTROVERSIES AND CHALLENGES
Giles, K. M., Hart, S. P., Haslett, C., Rossi, A. G., & Dransfield, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01805.x · Cited by 65
Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage
Soland, M. A., Bego, M. G., Colletti, E. J., Zanjani, E. D., Jeor, S. S., Porada, C. D., & Almeida-Porada, G. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060461 · Cited by 58
Sohn, H. S., Heo, J. S., Kim, H., Choi, Y., & Kim, H. O. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.10.015 · Cited by 55
Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
Stephenne, X., Nicastro, E., Eeckhoudt, S., Hermans, C., Nyabi, O., Lombard, C., Najimi, M., & Sokal, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042819 · Cited by 54
Ekdahl, K. N., Hong, J., Hamad, O. A., Larsson, R. L., & Nilsson, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_18 · Cited by 50
Self-citationFate of Intravenously Injected Mesenchymal Stem Cells and Significance for Clinical Application
Wagner, B., & Henschler, R. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_155 · Cited by 46
Oral Mucosal Progenitor Cells Are Potently Immunosuppressive in a Dose-Independent Manner
Davies, L. C., Lönnies, H., Locke, M., Sundberg, B., Rosendahl, K., Gotherstrom, C. O. T., Blanc, K. L., & Stephens, P. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0434 · Cited by 44
Self-citationGálvez‐Martín, P., Hmadcha, A., Soria, B., Calpena, A. C., & Clares, B. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.11.002 · Cited by 42
What do we mean when we write “senescence,”“apoptosis,”“necrosis,” or “clearance of dying cells”?
Mevorach, D., Trahtemberg, U., Krispin, A., Atallah, M., Zazoun, J., Tabib, A., Grau, A., & Verbovetski, I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05774.x · Cited by 31
Saas, P., Gaugler, B., & Perruche, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05741.x · Cited by 14
Cited by
Shattering barriers toward clinically meaningful MSC therapies
Levy, O., Kuai, R., Siren, E. M. J., Bhere, D., Milton, Y., Nissar, N., De Biasio, M., Heinelt, M., Reeve, B., Abdi, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba6884 · Cited by 694
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Moll, G., Ankrum, J. A., Kamhieh-Milz, J., Bieback, K., Ringdén, O., Volk, H.-D., Geissler, S., & Reinke, P. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.006 · Cited by 440
Self-citationMarquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E., & Elliott, J. A. W. (2015) · Cryobiology · doi:10.1016/j.cryobiol.2015.07.003 · Cited by 346
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
Liu, W., Song, F., Ren, L., Guo, W., Wang, T., Feng, Y., Tang, L., & Li, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12482 · Cited by 139
Metadata
- Authors
- Moll, G., Alm, J. J., Davies, L. C., von Bahr, L., Heldring, N., Stenbeck-Funke, L., Hamad, O. A., Hinsch, R., Ignatowicz, L., Locke, M., Lönnies, H., Lambris, J. D., Teramura, Y., Nilsson-Ekdahl, K., Nilsson, B., & Blanc, K.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-18
- Volume
- 32
- Issue
- 9
- Pages
- 2430-2442
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2116259052
- Cited by
- 381
- References
- 41
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
